Company News

AIO vape leakage has become a critical issue in 2026. This article explores the main causes of leaking devices and how leading manufacturers are improving hardware design, production processes, and oil compatibility to enhance product reliability in the U.S. market.

China vape price increase 2026
Vape hardware price increase
China VAT rebate cancellation vape
US tariffs on China vape products
Why are vape suppliers raising prices 2026

The U.S. vape market in 2026 is undergoing major transformation driven by stricter FDA regulations, rising supply chain costs, and shifting consumer preferences. As disposable vapes face increasing scrutiny, the industry is moving toward compliant, higher-quality, and experience-focused products, creating new challenges and opportunities for brands and distributors.

China vape export VAT rebate cancellation 2026
Vape industry after Chinese New Year 2026
Vape hardware price increase 2026
China vape tax policy impact
How U.S. buyers should prepare for vape cost changes in Q2 2026

2026 vape pricing reset
vape hardware pricing 2026
vape supplier risk 2026
U.S. vape buyer strategy

why vape hardware prices are rising in 2026
impact of battery rebate cuts on vape devices
China export VAT policy vape hardware
vape battery cost structure explained
multi-layer cost increase vape manufacturing

China vape export VAT rebate
China vape VAT rebate cancellation
China vape VAT policy 2026
vape export VAT China
China vape tax policy

Vape hardware prices are rising in 2026 due to China's VAT rebate cancellation and higher material costs.

Learn why this is an industry-wide cost reset, not a supplier decision.

The marijuana industry in the United States has been rapidly growing in recent years, driven by changing attitudes towards cannabis and its legalization for both medical and recreational use in many states. This industry encompasses various aspects, including cultivation, processing, distribution, and sales of marijuana products.

The DEA is planning to reclassify marijuana from a Schedule I to a Schedule III controlled substance. The shift, which would still require ultimate approval from the White House, could broaden access to use marijuana in the United States and may ease restrictions to conduct research on the drug，which could have a profound impact on US drug policy.